JANUS HENDERSON GROUP PLC - DAY ONE BIOPHARMACEUTICALS I ownership

DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 67 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of DAY ONE BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$10,075,123
+22.8%
821,453
+19.5%
0.01%
+40.0%
Q2 2023$8,205,434
+9.0%
687,510
+22.2%
0.01%0.0%
Q1 2023$7,530,181
-15.8%
562,794
-37.6%
0.01%
+25.0%
Q1 2022$8,948,000
-46.1%
902,020
-11.8%
0.00%
-42.9%
Q4 2021$16,605,000
-29.0%
1,022,548
+0.0%
0.01%
-30.0%
Q3 2021$23,384,000
-16.1%
1,022,483
-21.2%
0.01%
-16.7%
Q2 2021$27,862,0001,297,7700.01%
Other shareholders
DAY ONE BIOPHARMACEUTICALS I shareholders Q1 2022
NameSharesValueWeighting ↓
Canaan Partners XI LLC 2,491,561$30,571,45326.81%
Atlas Venture Life Science Advisors, LLC 7,608,394$93,354,99414.46%
DAFNA Capital Management LLC 586,463$7,195,9012.24%
Nicholas Investment Partners, LP 2,188,654$26,854,7852.01%
RA Capital Management 7,809,852$95,826,8841.89%
BRAIDWELL LP 3,715,573$45,590,0811.44%
PFM Health Sciences, LP 2,224,598$27,295,8171.29%
SPHERA FUNDS MANAGEMENT LTD. 530,000$6,503,1001.18%
COMMODORE CAPITAL LP 739,661$9,075,6401.06%
Parkman Healthcare Partners LLC 466,408$5,722,8261.05%
View complete list of DAY ONE BIOPHARMACEUTICALS I shareholders